Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including cancer, asthma, pain and infectious diseases.
In addition to our medicines, our innovations include the VelociSuite® technologies, world-class manufacturing operations, one of the largest human sequencing efforts in the world and rapid response technologies being used for global good.
$381.72 0.00 (0.00)%
Market Cap 40.28B
12/12/17 4:00 PM ET | Minimum 20 minutes delay.
Stock information provided by eSignal.
ASH 2017 Presentations
Dec 9, 2017
29th Annual Piper Jaffray Healthcare Conference
Nov 28, 2017 | 4:00 PM ET